The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...

The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

The National Community Pharmacists Association (NPCA) is warning the feds that independent pharmacists are likely to face ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

Soon, the Centers for Medicare and Medicaid Services will begin the price negotiation process on a new set of 15 drugs. The new Trump administration should seize the opportunity to change the ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Why would Trump be OK with forcing Americans to pay more than the rest of the world for their drugs? The answer is simple: ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.